CoChat

Discovering Genes Essential to the Hypothalamic Regulation of Human Reproduction Using a Human Disease Model: Adjusting to Life in the “-Omics” Era

Open access
Stamou, M. I., Cox, K. H., Crowley, William F. · 2015 · Endocrine Reviews
Cited by 88

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

The neuroendocrine regulation of reproduction is an intricate process requiring the exquisite coordination of an assortment of cellular networks, all converging on the GnRH neurons. These neurons have a complex life history, migrating mainly from the olfactory placode into the hypothalamus, where GnRH is secreted and acts as the master regulator of the hypothalamic-pituitary-gonadal axis. Much of what we know about the biology of the GnRH neurons has been aided by discoveries made using the human disease model of isolated GnRH deficiency (IGD), a family of rare Mendelian disorders that share a common failure of secretion and/or action of GnRH causing hypogonadotropic hypogonadism. Over the last 30 years, research groups around the world have been investigating the genetic basis of IGD using different strategies based on complex cases that harbor structural abnormalities or single pleiotropic genes, endogamous pedigrees, candidate gene approaches as well as pathway gene analyses. Although such traditional approaches, based on well-validated tools, have been critical to establish the field, new strategies, such as next-generation sequencing, are now providing speed and robustness, but also revealing a surprising number of variants in known IGD genes in both patients and healthy controls. Thus, before the field moves forward with new genetic tools and continues discovery efforts, we must reassess what we know about IGD genetics and prepare to hold our work to a different standard. The purpose of this review is to: 1) look back at the strategies used to discover the “known” genes implicated in the rare forms of IGD; 2) examine the strengths and weaknesses of the methodologies used to validate genetic variation; 3) substantiate the role of known genes in the pathophysiology of the disease; and 4) project forward as we embark upon a widening use of these new and powerful technologies for gene discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/er.2015-1045This paper is marked retracted.

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 122

  1. Schlosser, 2010, Making senses development of vertebrate cranial placodes, Int Rev Cell Mol Biol, 283, 129, 10.1016/S1937-6448(10)83004-7 · DOI · Paper page
  2. Forni, 2011, Neural crest and ectodermal cells intermix in the nasal placode to give rise to GnRH-1 neurons, sensory neurons, and olfactory ensheathing cells, J Neurosci, 31, 6915, 10.1523/JNEUROSCI.6087-10.2011 · DOI · Paper page
  3. Wray, 1989, Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode, Proc Natl Acad Sci USA, 86, 8132, 10.1073/pnas.86.20.8132 · DOI · Paper page
  4. Whitlock, 2006, Development of GnRH cells: setting the stage for puberty, Mol Cell Endocrinol, 254–255, 39, 10.1016/j.mce.2006.04.038 · DOI
  5. Schwanzel-Fukuda, 1996, Migration of luteinizing hormone-releasing hormone (LHRH) neurons in early human embryos, J Comp Neurol, 366, 547, 10.1002/(SICI)1096-9861(19960311)366:3<547::AID-CNE12>3.0.CO;2-M · DOI · Paper page
  6. Belchetz, 1978, Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone, Science, 202, 631, 10.1126/science.100883 · DOI · Paper page
  7. Balasubramanian, 2011, Isolated GnRH deficiency: a disease model serving as a unique prism into the systems biology of the GnRH neuronal network, Mol Cell Endocrinol, 346, 4, 10.1016/j.mce.2011.07.012 · DOI · Paper page
  8. Sykiotis, 2010, Deciphering genetic disease in the genomic era: the model of GnRH deficiency, Sci Transl Med, 2, 32rv32, 10.1126/scitranslmed.3000288 · DOI · Paper page
  9. Bonomi, 2012, New understandings of the genetic basis of isolated idiopathic central hypogonadism, Asian J Androl, 14, 49, 10.1038/aja.2011.68 · DOI
  10. Valdes-Socin, 2014, Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes, Front Endocrinol (Lausanne), 5, 109, 10.3389/fendo.2014.00109 · DOI · Paper page
  11. Balasubramanian, 2010, Human GnRH deficiency: a unique disease model to unravel the ontogeny of GnRH neurons, Neuroendocrinology, 92, 81, 10.1159/000314193 · DOI · Paper page
  12. Dodé, 2009, Kallmann syndrome, Eur J Hum Genet, 17, 139, 10.1038/ejhg.2008.206 · DOI · Paper page
  13. Laitinen, 2011, Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland, Orphanet J Rare Dis, 6, 41, 10.1186/1750-1172-6-41 · DOI · Paper page
  14. Crowley, 2011, The developmental biology of the GnRH neurons, Mol Cell Endocrinol, 346, 1, 10.1016/j.mce.2011.06.023 · DOI
  15. Bouloux, 1992, Sex and smell–an enigma resolved, J Endocrinol, 133, 323, 10.1677/joe.0.1330323 · DOI
  16. Kallmann, 1944, The genetic aspects of primary eunuchoidism, Am J Ment Defic, 48, 203
  17. Quinton, 1996, The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis, J Clin Endocrinol Metab, 81, 3010
  18. Zhu, 2015, A shared genetic basis for self-limited delayed puberty and idiopathic hypogonadotropic hypogonadism, J Clin Endocrinol Metab, 100, E646, 10.1210/jc.2015-1080 · DOI · Paper page
  19. Quinton, 2001, Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization, Clin Endocrinol (Oxf), 55, 163, 10.1046/j.1365-2265.2001.01277.x · DOI · Paper page
  20. Costa-Barbosa, 2013, Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes, J Clin Endocrinol Metab, 98, E943, 10.1210/jc.2012-4116 · DOI · Paper page
  21. Seminara, 1998, Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations, Endocr Rev, 19, 521
  22. Sykiotis, 2010, Oligogenic basis of isolated gonadotropin-releasing hormone deficiency, Proc Natl Acad Sci USA, 107, 15140, 10.1073/pnas.1009622107 · DOI · Paper page
  23. Quaynor, 2011, The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome, Fertil Steril, 96, 1424, 10.1016/j.fertnstert.2011.09.046 · DOI · Paper page
  24. Turner, 1938, A syndrome of infantilism, congenital webbed neck, and cubrtus valgus, Endocrinology, 23, 566, 10.1210/endo-23-5-566 · DOI · Paper page
  25. Klinefelter, 1942, Syndrome characterized by gynecomastia, aspermatogenesis without a-leydigsm and increased secretion of follicle-stimulating hormone, J Clin Endocrinol Metab, 615, 10.1210/jcem-2-11-615 · DOI · Paper page
  26. Schwanzel-Fukuda, 1989, Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome, Brain Res Mol Brain Res, 6, 311, 10.1016/0169-328X(89)90076-4 · DOI · Paper page
  27. Bick, 1989, Male infant with ichthyosis, Kallmann syndrome, chondrodysplasia punctata, and an Xp chromosome deletion, Am J Med Genet, 33, 100, 10.1002/ajmg.1320330114 · DOI · Paper page
  28. Ballabio, 1986, X-linked ichthyosis, due to steroid sulphatase deficiency, associated with Kallmann syndrome (hypogonadotropic hypogonadism and anosmia): linkage relationships with Xg and cloned DNA sequences from the distal short arm of the X chromosome, Hum Genet, 72, 237, 10.1007/BF00291885 · DOI
  29. Ballabio, 1991, Deletion of the distal short arm of the X chromosome (Xp) in a patient with short stature, chondrodysplasia punctata, and X-linked ichthyosis due to steroid sulfatase deficiency, Am J Med Genet, 41, 184, 10.1002/ajmg.1320410210 · DOI
  30. Petit, 1990, Long-range restriction map of the terminal part of the short arm of the human X chromosome, Proc Natl Acad Sci USA, 87, 3680, 10.1073/pnas.87.10.3680 · DOI · Paper page
  31. Vermeulen, 2002, Kallmann syndrome in a patient with congenital spherocytosis and an interstitial 8p11.2 deletion, Am J Med Genet, 108, 315, 10.1002/ajmg.10295 · DOI
  32. Dodé, 2003, Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome, Nat Genet, 33, 463, 10.1038/ng1122 · DOI · Paper page
  33. Pitteloud, 2006, Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism, Proc Natl Acad Sci USA, 103, 6281, 10.1073/pnas.0600962103 · DOI · Paper page
  34. Kim, 2005, Hypogonadotropic hypogonadism and cleft lip and palate caused by a balanced translocation producing haploinsufficiency for FGFR1, J Med Genet, 42, 666, 10.1136/jmg.2004.026989 · DOI · Paper page
  35. Young, 2012, SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development, Hum Reprod, 27, 1460, 10.1093/humrep/des022 · DOI · Paper page
  36. Seminara, 1999, X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females, J Clin Endocrinol Metab, 84, 4501
  37. Muscatelli, 1994, Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, Nature, 372, 672, 10.1038/372672a0 · DOI · Paper page
  38. Margolin, 2013, Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination, N Engl J Med, 368, 1992, 10.1056/NEJMoa1215993 · DOI · Paper page
  39. Topaloglu, 2014, Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome, J Clin Endocrinol Metab, 99, E2067, 10.1210/jc.2014-1836 · DOI · Paper page
  40. Shi, 2014, Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP, Hum Mol Genet, 23, 1013, 10.1093/hmg/ddt497 · DOI · Paper page
  41. Bernard, 2011, Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy, Am J Hum Genet, 89, 415, 10.1016/j.ajhg.2011.07.014 · DOI · Paper page
  42. Tétreault, 2011, Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy, Am J Hum Genet, 89, 652, 10.1016/j.ajhg.2011.10.006 · DOI · Paper page
  43. Abid, 1978, Moebius syndrome, peripheral neuropathy and hypogonadotrophic hypogonadism, J Neurol Sci, 35, 309, 10.1016/0022-510X(78)90011-4 · DOI
  44. Chew, 2013, A novel syndrome caused by the E410K amino acid substitution in the neuronal β-tubulin isotype 3, Brain, 136, 522, 10.1093/brain/aws345 · DOI · Paper page
  45. Balasubramanian, 2015, Expanding the phenotypic spectrum and variability of endocrine abnormalities associated with TUBB3 E410K syndrome, J Clin Endocrinol Metab, 100, E473, 10.1210/jc.2014-4107 · DOI
  46. Kim, 2008, Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome, Am J Hum Genet, 83, 511, 10.1016/j.ajhg.2008.09.005 · DOI · Paper page
  47. Jongmans, 2009, CHD7 mutations in patients initially diagnosed with Kallmann syndrome–the clinical overlap with CHARGE syndrome, Clin Genet, 75, 65, 10.1111/j.1399-0004.2008.01107.x · DOI · Paper page
  48. Marcos, 2014, The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients, J Clin Endocrinol Metab, 99, E2138, 10.1210/jc.2014-2110 · DOI · Paper page
  49. Pingault, 2013, Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness, Am J Hum Genet, 92, 707, 10.1016/j.ajhg.2013.03.024 · DOI · Paper page
  50. Lang, 2003, Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer, Hum Mol Genet, 12, 937, 10.1093/hmg/ddg107 · DOI · Paper page
  51. Bondurand, 2000, Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome, Hum Mol Genet, 9, 1907, 10.1093/hmg/9.13.1907 · DOI · Paper page
  52. Schulz, 2014, CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance, Hum Genet, 133, 997, 10.1007/s00439-014-1444-2 · DOI
  53. Gürbüz, 2012, Distribution of gene mutations associated with familial normosmic idiopathic hypogonadotropic hypogonadism, J Clin Res Pediatr Endocrinol, 4, 121, 10.4274/Jcrpe.725 · DOI
  54. Chan, 2011, GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1, J Clin Endocrinol Metab, 96, E1771, 10.1210/jc.2011-0518 · DOI · Paper page
  55. Kotan, 2014, Mutations in FEZF1 cause Kallmann syndrome, Am J Hum Genet, 95, 326, 10.1016/j.ajhg.2014.08.006 · DOI
  56. Tata, 2014, Haploinsufficiency of Dmxl2, encoding a synaptic protein, causes infertility associated with a loss of GnRH neurons in mouse, PLoS Biol, 12, e1001952, 10.1371/journal.pbio.1001952 · DOI · Paper page
  57. Chan, 2009, GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism, Proc Natl Acad Sci USA, 106, 11703, 10.1073/pnas.0903449106 · DOI · Paper page
  58. Kramer, 2000, Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons, Genes Dev, 14, 1824, 10.1101/gad.14.14.1824 · DOI · Paper page
  59. Miura, 2004, Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH), J Hum Genet, 49, 265, 10.1007/s10038-004-0137-4 · DOI
  60. Salian-Mehta, 2014, Functional consequences of AXL sequence variants in hypogonadotropic hypogonadism, J Clin Endocrinol Metab, 99, 1452, 10.1210/jc.2013-3426 · DOI
  61. Pierce, 2008, Axl and Tyro3 modulate female reproduction by influencing gonadotropin-releasing hormone neuron survival and migration, Mol Endocrinol, 22, 2481, 10.1210/me.2008-0169 · DOI · Paper page
  62. Radovick, 1991, Migratory arrest of gonadotropin-releasing hormone neurons in transgenic mice, Proc Natl Acad Sci USA, 88, 3402, 10.1073/pnas.88.8.3402 · DOI · Paper page
  63. Mellon, 1990, Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis, Neuron, 5, 1, 10.1016/0896-6273(90)90028-E · DOI · Paper page
  64. Moenter, 2010, Identified GnRH neuron electrophysiology: a decade of study, Brain Res, 1364, 10, 10.1016/j.brainres.2010.09.066 · DOI · Paper page
  65. Fueshko, 1994, LHRH cells migrate on peripherin fibers in embryonic olfactory explant cultures: an in vitro model for neurophilic neuronal migration, Dev Biol, 166, 331, 10.1006/dbio.1994.1319 · DOI · Paper page
  66. Herbison, 2001, Molecular and cellular properties of GnRH neurons revealed through transgenics in the mouse, Mol Cell Endocrinol, 185, 185, 10.1016/S0303-7207(01)00618-9 · DOI
  67. Lippincott, 2013, Use of genetic models of idiopathic hypogonadotrophic hypogonadism in mice and men to understand the mechanisms of disease, Exp Physiol, 98, 1522, 10.1113/expphysiol.2013.071910 · DOI
  68. Kumar, 2013, Genetic dissection of puberty in mice, Exp Physiol, 98, 1528, 10.1113/expphysiol.2013.071928 · DOI
  69. Cariboni, 2015, Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome, J Clin Invest, 125, 2413, 10.1172/JCI78448 · DOI · Paper page
  70. Crowley, 2011, Commentary: the year in endocrine genetics for basic scientists, Mol Endocrinol, 25, 1989, 10.1210/me.2011-1247 · DOI
  71. Abecasis, 2012, An integrated map of genetic variation from 1,092 human genomes, Nature, 491, 56, 10.1038/nature11632 · DOI · Paper page
  72. Noel, 2011, G protein-coupled receptors involved in GnRH regulation: molecular insights from human disease, Mol Cell Endocrinol, 346, 91, 10.1016/j.mce.2011.06.022 · DOI
  73. Giallourakis, 2005, Disease gene discovery through integrative genomics, Annu Rev Genomics Hum Genet, 6, 381, 10.1146/annurev.genom.6.080604.162234 · DOI · Paper page
  74. MacArthur, 2014, Guidelines for investigating causality of sequence variants in human disease, Nature, 508, 469, 10.1038/nature13127 · DOI · Paper page
  75. Wu, 2009, BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources, Genome Biol, 10, R130, 10.1186/gb-2009-10-11-r130 · DOI · Paper page
  76. Kapushesky, 2010, Gene expression atlas at the European bioinformatics institute, Nucleic Acids Res, 38, D690, 10.1093/nar/gkp936 · DOI · Paper page
  77. Forrest, 2014, A promoter-level mammalian expression atlas, Nature, 507, 462, 10.1038/nature13182 · DOI · Paper page
  78. Kapushesky, 2012, Gene Expression Atlas update–a value-added database of microarray and sequencing-based functional genomics experiments, Nucleic Acids Res, 40, D1077, 10.1093/nar/gkr913 · DOI · Paper page
  79. Uhlen, 2015, Proteomics. Tissue-based map of the human proteome, Science, 347, 1260419, 10.1126/science.1260419 · DOI · Paper page
  80. Liu, 2008, TiGER: a database for tissue-specific gene expression and regulation, BMC Bioinformatics, 9, 271, 10.1186/1471-2105-9-271 · DOI · Paper page
  81. Soussi-Yanicostas, 1996, Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system, J Cell Sci, 109, 1749, 10.1242/jcs.109.7.1749 · DOI · Paper page
  82. Pellegrini, 2001, Role of heparan sulfate in fibroblast growth factor signalling: a structural view, Curr Opin Struct Biol, 11, 629, 10.1016/S0959-440X(00)00258-X · DOI · Paper page
  83. Ayari, 2007, FGFR1 and anosmin-1 underlying genetically distinct forms of Kallmann syndrome are co-expressed and interact in olfactory bulbs, Dev Genes Evol, 217, 169, 10.1007/s00427-006-0125-0 · DOI · Paper page
  84. Navarro, 2009, Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse, J Neurosci, 29, 11859, 10.1523/JNEUROSCI.1569-09.2009 · DOI · Paper page
  85. Smith, 2005, Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse, Endocrinology, 146, 2976, 10.1210/en.2005-0323 · DOI · Paper page
  86. Navarro, 2011, Kisspeptins and the neuroendocrine control of reproduction, Front Biosci (Schol Ed), 3, 267, 10.2741/s150 · DOI · Paper page
  87. García-Galiano, 2012, Sex steroids and the control of the Kiss1 system: developmental roles and major regulatory actions, J Neuroendocrinol, 24, 22, 10.1111/j.1365-2826.2011.02230.x · DOI · Paper page
  88. Li, 2015, Evidence that nurokinin B controls basal gonadotropin-releasing hormone secretion but is not critical for estrogen-positive feedback in sheep, Neuroendocrinology, 101, 161, 10.1159/000377702 · DOI
  89. Grachev, 2014, The role of neurokinin B signalling in reproductive neuroendocrinology, Neuroendocrinology, 99, 7, 10.1159/000357734 · DOI
  90. True, 2015, Neurokinin B is critical for normal timing of sexual maturation but dispensable for adult reproductive function in female mice, Endocrinology, 156, 1386, 10.1210/en.2014-1862 · DOI · Paper page
  91. Krajewski, 2010, Forebrain projections of arcuate neurokinin B neurons demonstrated by anterograde tract-tracing and monosodium glutamate lesions in the rat, Neuroscience, 166, 680, 10.1016/j.neuroscience.2009.12.053 · DOI · Paper page
  92. Mason, 1987, Gonadal development and gametogenesis in the hypogonadal mouse are restored by gene transfer, Ann NY Acad Sci, 513, 16, 10.1111/j.1749-6632.1987.tb24995.x · DOI
  93. d'Anglemont de Tassigny, 2007, Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene, Proc Natl Acad Sci USA, 104, 10714, 10.1073/pnas.0704114104 · DOI · Paper page
  94. Janovick, 2002, Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target, J Clin Endocrinol Metab, 87, 3255, 10.1210/jcem.87.7.8582 · doi:10.1210/jcem.87.7.8582 · Paper page
  95. Yanicostas, 2009, Anosmin-1a is required for fasciculation and terminal targeting of olfactory sensory neuron axons in the zebrafish olfactory system, Mol Cell Endocrinol, 312, 53, 10.1016/j.mce.2009.04.017 · DOI
  96. Janovick, 2013, Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy, Proc Natl Acad Sci USA, 110, 21030, 10.1073/pnas.1315194110 · DOI
  97. Zhang, 2010, A fertile male patient with Kallmann syndrome and two missense mutations in the KAL1 gene, Fertil Steril, 95, 1789.e1783
  98. Zhang, 2013, The KAL1 pVal610Ile mutation is a recessive mutation causing Kallmann syndrome, Fertil Steril, 99, 1720, 10.1016/j.fertnstert.2013.01.099 · DOI
  99. Sato, 2004, Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients, J Clin Endocrinol Metab, 89, 1079, 10.1210/jc.2003-030476 · DOI · Paper page
  100. Layman, 1998, Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism, Nat Genet, 18, 14, 10.1038/ng0198-14 · DOI · Paper page
  101. Trarbach, 2006, Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia, J Clin Endocrinol Metab, 91, 4006, 10.1210/jc.2005-2793 · DOI · Paper page
  102. Dodé, 2007, Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis, Hum Mutat, 28, 97, 10.1002/humu.9470 · DOI · Paper page
  103. Raivio, 2009, Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism, J Clin Endocrinol Metab, 94, 4380, 10.1210/jc.2009-0179 · DOI · Paper page
  104. Semple, 2005, Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism, J Clin Endocrinol Metab, 90, 1849, 10.1210/jc.2004-1418 · DOI · Paper page
  105. Cerrato, 2006, Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism, Eur J Endocrinol, 155, S3, 10.1530/eje.1.02235 · DOI · Paper page
  106. Teles, 2010, A novel homozygous splice acceptor site mutation of KISS1R in two siblings with normosmic isolated hypogonadotropic hypogonadism, Eur J Endocrinol, 163, 29, 10.1530/EJE-10-0012 · DOI
  107. Känsäkoski, 2014, Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism, Pediatr Res, 75, 641, 10.1038/pr.2014.23 · DOI
  108. Vaaralahti, 2014, De novo SOX10 nonsense mutation in a patient with Kallmann syndrome and hearing loss, Pediatr Res, 76, 115, 10.1038/pr.2014.60 · DOI
  109. Xu, 2011, Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome, Fertil Steril, 95, 1613, 10.1016/j.fertnstert.2011.01.010 · DOI · Paper page
  110. Kim, 2010, WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome, Am J Hum Genet, 87, 465, 10.1016/j.ajhg.2010.08.018 · DOI · Paper page
  111. Shaw, 2011, Expanding the phenotype and genotype of female GnRH deficiency, J Clin Endocrinol Metab, 96, E566, 10.1210/jc.2010-2292 · DOI · Paper page
  112. Lim, 2014, Distribution and medical impact of loss-of-function variants in the Finnish founder population, PLoS Genet, 10, e1004494, 10.1371/journal.pgen.1004494 · DOI · Paper page
  113. Sarfati, 2013, Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients, Eur J Endocrinol, 169, 805, 10.1530/EJE-13-0419 · DOI
  114. Avbelj Stefanija, 2012, An ancient founder mutation in PROKR2 impairs human reproduction, Hum Mol Genet, 21, 4314, 10.1093/hmg/dds264 · DOI
  115. Talkowski, 2012, Clinical diagnosis by whole-genome sequencing of a prenatal sample, N Engl J Med, 367, 2226, 10.1056/NEJMoa1208594 · DOI · Paper page
  116. Perry, 2013, A genome-wide association study of early menopause and the combined impact of identified variants, Hum Mol Genet, 22, 1465, 10.1093/hmg/dds551 · DOI
  117. Carty, 2013, Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) study, Hum Reprod, 28, 1695, 10.1093/humrep/det071 · DOI · Paper page
  118. Rahmani, 2013, Shared genetic factors for age at natural menopause in Iranian and European women, Hum Reprod, 28, 1987, 10.1093/humrep/det106 · DOI
  119. Chen, 2014, Meta-analysis of loci associated with age at natural menopause in African-American women, Hum Mol Genet, 23, 3327, 10.1093/hmg/ddu041 · DOI
  120. Holoch, 2015, RNA-mediated epigenetic regulation of gene expression, Nat Rev Genet, 16, 71, 10.1038/nrg3863 · DOI · Paper page
  121. Guil, 2015, RNA-RNA interactions in gene regulation: the coding and noncoding players, Trends Biochem Sci, 40, 248, 10.1016/j.tibs.2015.03.001 · DOI · Paper page
  122. Lomniczi, 2013, Epigenetic control of female puberty, Nat Neurosci, 16, 281, 10.1038/nn.3319 · DOI · Paper page

Cited by

See all 88

Metadata

Authors
Stamou, M. I., Cox, K. H., & Crowley, W. F.
Venue
Endocrine Reviews
Published
2015-12-01
Volume
36
Issue
6
Pages
603-621
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W1650584138
Cited by
88
References
39
FWCI
6.88
Type
journal article
Language
en
Status
Retracted
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.